1. Home
  2. ALDX vs BLUW Comparison

ALDX vs BLUW Comparison

Compare ALDX & BLUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • BLUW
  • Stock Information
  • Founded
  • ALDX 2004
  • BLUW 2024
  • Country
  • ALDX United States
  • BLUW United States
  • Employees
  • ALDX N/A
  • BLUW N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • BLUW
  • Sector
  • ALDX Health Care
  • BLUW
  • Exchange
  • ALDX Nasdaq
  • BLUW Nasdaq
  • Market Cap
  • ALDX 342.3M
  • BLUW 322.1M
  • IPO Year
  • ALDX 2014
  • BLUW 2025
  • Fundamental
  • Price
  • ALDX $5.39
  • BLUW $9.99
  • Analyst Decision
  • ALDX Strong Buy
  • BLUW
  • Analyst Count
  • ALDX 2
  • BLUW 0
  • Target Price
  • ALDX $9.50
  • BLUW N/A
  • AVG Volume (30 Days)
  • ALDX 772.4K
  • BLUW 120.3K
  • Earning Date
  • ALDX 11-06-2025
  • BLUW 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • BLUW N/A
  • EPS Growth
  • ALDX N/A
  • BLUW N/A
  • EPS
  • ALDX N/A
  • BLUW N/A
  • Revenue
  • ALDX N/A
  • BLUW N/A
  • Revenue This Year
  • ALDX N/A
  • BLUW N/A
  • Revenue Next Year
  • ALDX $43.00
  • BLUW N/A
  • P/E Ratio
  • ALDX N/A
  • BLUW N/A
  • Revenue Growth
  • ALDX N/A
  • BLUW N/A
  • 52 Week Low
  • ALDX $1.14
  • BLUW $9.93
  • 52 Week High
  • ALDX $7.20
  • BLUW $10.05
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 45.98
  • BLUW N/A
  • Support Level
  • ALDX $5.48
  • BLUW N/A
  • Resistance Level
  • ALDX $5.88
  • BLUW N/A
  • Average True Range (ATR)
  • ALDX 0.27
  • BLUW 0.00
  • MACD
  • ALDX -0.07
  • BLUW 0.00
  • Stochastic Oscillator
  • ALDX 1.87
  • BLUW 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About BLUW Blue Water Acquisition Corp. III Class A Ordinary Shares

Blue Water Acquisition Corp III is a blank check company.

Share on Social Networks: